Goeltz Ii Robert C. - Net Worth and Insider Trading
Goeltz Ii Robert C. Net Worth
The estimated net worth of Goeltz Ii Robert C. is at least $821,537 dollars as of 2024-04-28. Goeltz Ii Robert C. is the CFO of Arcus Biosciences Inc and owns about 51,831 shares of Arcus Biosciences Inc (RCUS) stock worth over $805,972. Goeltz Ii Robert C. is also the CFO of CytomX Therapeutics Inc and owns about 9,789 shares of CytomX Therapeutics Inc (CTMX) stock worth over $15,565. Details can be seen in Goeltz Ii Robert C.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Goeltz Ii Robert C. has not made any transactions after 2024-01-02 and currently still holds the listed stock(s).
Transaction Summary of Goeltz Ii Robert C.
Goeltz Ii Robert C. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Goeltz Ii Robert C. owns 3 companies in total, including Arcus Biosciences Inc (RCUS) , Unity Biotechnology Inc (UBX) , and CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Goeltz Ii Robert C.’s form 4 insider trades.
Insider Ownership Summary of Goeltz Ii Robert C.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2024-01-02 | Chief Financial Officer |
| UBX | Unity Biotechnology Inc | 2018-10-10 | Chief Financial Officer |
| CTMX | CytomX Therapeutics Inc | 2017-03-20 | Chief Financial Officer |
Goeltz Ii Robert C. Latest Holdings Summary
Goeltz Ii Robert C. currently owns a total of 2 stocks. Among these stocks, Goeltz Ii Robert C. owns 51,831 shares of Arcus Biosciences Inc (RCUS) as of January 2, 2024, with a value of $805,972 and a weighting of 98.11%. Goeltz Ii Robert C. also owns 9,789 shares of CytomX Therapeutics Inc (CTMX) as of March 20, 2017, with a value of $15,565 and a weighting of 1.89%.
Latest Holdings of Goeltz Ii Robert C.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences Inc | 2024-01-02 | 51,831 | 15.55 | 805,972 |
| CTMX | CytomX Therapeutics Inc | 2017-03-20 | 9,789 | 1.59 | 15,565 |
Holding Weightings of Goeltz Ii Robert C.
Goeltz Ii Robert C. Form 4 Trading Tracker
According to the SEC Form 4 filings, Goeltz Ii Robert C. has made a total of 5 transactions in Arcus Biosciences Inc (RCUS) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Arcus Biosciences Inc is the sale of 2,004 shares on January 2, 2024, which brought Goeltz Ii Robert C. around $40,080.
According to the SEC Form 4 filings, Goeltz Ii Robert C. has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 21,517 shares on March 20, 2017, which brought Goeltz Ii Robert C. around $426,252.
Insider Trading History of Goeltz Ii Robert C.
- 1
Goeltz Ii Robert C. Trading Performance
GuruFocus tracks the stock performance after each of Goeltz Ii Robert C.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Goeltz Ii Robert C. is 34.93%. GuruFocus also compares Goeltz Ii Robert C.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Goeltz Ii Robert C. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Goeltz Ii Robert C.'s insider trading performs compared to the benchmark.
Performance of Goeltz Ii Robert C.
Average Return
58.23%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.79 | 34.93 | 48.81 | 58.23 | 8.17 | -0.59 |
| Relative Return to S&P 500(%) | -12.09 | 26.87 | 34.79 | 26.03 | -1.22 | -10.06 |
Goeltz Ii Robert C. Ownership Network
Ownership Network List of Goeltz Ii Robert C.
Ownership Network Relation of Goeltz Ii Robert C.
Goeltz Ii Robert C. Owned Company Details
What does Arcus Biosciences Inc do?
Who are the key executives at Arcus Biosciences Inc?
Goeltz Ii Robert C. is the Chief Financial Officer of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include See Remarks Jennifer Jarrett , director & 10 percent owner & President Juan C. Jaen , and 10 percent owner Gilead Sciences Inc .
Arcus Biosciences Inc (RCUS) Insider Trades Summary
Over the past 18 months, Goeltz Ii Robert C. made 3 insider transaction in Arcus Biosciences Inc (RCUS) with a net sale of 8,506. Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 38,443 shares made by Juan C. Jaen , and a net purchase of 16,248,095 shares made by Gilead Sciences Inc .
In summary, during the past 3 months, insiders sold 110,657 shares of Arcus Biosciences Inc (RCUS) in total and bought 15,238,095 shares, with a net purchase of 15,127,438 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.
Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcus Biosciences Inc Insider Transactions
Goeltz Ii Robert C. Mailing Address
Above is the net worth, insider trading, and ownership report for Goeltz Ii Robert C.. You might contact Goeltz Ii Robert C. via mailing address: 343 Oyster Point Blvd, Suite 100, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
